BioMarin Pharmaceutical <BMRN.O>: Oppenheimer raises target price to $97 from $95
BMRN•Related News
Angi Inc <ANGI.O>: UBS cuts target price to $5 from $11
ANGI•
StandardAero, Inc. <SARO.N>: UBS raises target price to $36 from $35
SARO•
A10 Networks Inc Files For Mixed Shelf Offering Size Not Disclosed- SEC Filing
ATEN•
Millrose Properties To Provide Capital Support For Dream Finders Homes' Announced Acquisition Of Beazer Homes With Up To $1.25 Billion Commitment
MRP•
abrdn Asia-Pacific Income Fund NAV at $ 5.39 as of Aug. 6, 2026
FAX•